Summary
Gilead Sciences, Inc. (GILD) filed an 8-K on July 26, 2012, announcing its financial results for the second quarter and the first six months ended June 30, 2012. The report primarily serves to attach the press release detailing these results, which includes both Generally Accepted Accounting Principles (GAAP) and non-GAAP financial measures. Management highlighted the utility of non-GAAP figures for investors, asserting they provide additional insight for operational and financial planning purposes. Investors are encouraged to review the accompanying press release for the detailed reconciliation between GAAP and non-GAAP reporting.
Key Highlights
- 1Gilead Sciences announced its Q2 and H1 2012 financial results via an 8-K filing on July 26, 2012.
- 2The filing's primary purpose is to furnish the press release containing the financial results as an exhibit.
- 3Both GAAP and non-GAAP financial information for the periods ended June 30, 2012, and June 30, 2011, were presented.
- 4Gilead's management views non-GAAP financial information as a valuable supplement to GAAP for understanding operating results.
- 5Non-GAAP metrics are used internally by management for operational, budgeting, and financial planning.
- 6Investors are directed to the press release (Exhibit 99.1) for a reconciliation of GAAP and non-GAAP figures.
- 7Information provided in this 8-K and its exhibit is not considered 'filed' for the purposes of Section 18 of the Exchange Act.